Работы, на которые ссылается эта работа

Работ: 175

Работа: CAR-T cell combination therapy: the next revolution in cancer treatment

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Levi J. Rupp, Kathrin Schumann, Kole T. Roybal +4
Статья2017Цитирований: 4
ABI
Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
Miyuki Tanaka, Haruko Tashiro, Bilal Omer +9
Статья2017Цитирований: 3
ABI
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai +18
Статья2017Цитирований: 3
ABI
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma
Tobias Weiß, Michael Weller, Matthias Gückenberger +2
Статья2017Цитирований: 3
ABI
CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
Wanghong Hu, Zhenguo Zi, Yanling Jin +5
Статья2018Цитирований: 3
ABI
Oncolytic virotherapy
Stephen J. Russell, Kah-Whye Peng, John C. Bell
Обзорная статья2012Цитирований: 3
ABI
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang, Ji Nie, Xuelei Ma +3
Обзорная статья2019Цитирований: 2
ABI
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E. Brown, Behnam Badie, Michael E. Barish +14
Статья2015Цитирований: 2
ABI
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Sandra Demaria, Bruce Ng, M. Devitt +4
Статья2004Цитирований: 2
ABI
Interleukin-7 Mediates Selective Expansion of Tumor-redirected Cytotoxic T Lymphocytes (CTLs) without Enhancement of Regulatory T-cell Inhibition
Serena Perna, Daria Pagliara, Aruna Mahendravada +4
Статья2013Цитирований: 2
ABI
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
Omkar U. Kawalekar, Roddy S. O’Connor, Joseph A. Fraietta +11
Статья2016Цитирований: 2
ABI
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
Leonid Cherkassky, Aurore Morello, Jonathan Villena‐Vargas +5
Статья2016Цитирований: 2
ABI
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
Lenka V. Hurton, Harjeet Singh, Amer Najjar +12
Статья2016Цитирований: 2
ABI
The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
Bertrand Allard, Maria Serena Longhi, Simon C. Robson +1
Обзорная статья2017Цитирований: 2
ABI
Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
Amanda Rosewell Shaw, Caroline E. Porter, Norihiro Watanabe +5
Статья2017Цитирований: 2
ABI
CAR-T cells and combination therapies: What’s next in the immunotherapy revolution?
María C. Ramello, Eric B. Haura, Daniel Abate‐Daga
Статья2017Цитирований: 2
ABI
Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines
Edmund K. Moon, Liang‐Chuan S. Wang, Kheng Bekdache +4
Статья2017Цитирований: 2
ABI
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando +34
Статья2018Цитирований: 2
ABI
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Mohamed-Reda Benmebarek, Clara H. Karches, Bruno L. Cadilha +3
Обзорная статья2019Цитирований: 2
ABI
A review of bispecific antibodies and antibody constructs in oncology and clinical challenges
Frans V. Suurs, Marjolijn N. Lub–de Hooge, Elisabeth G.E. de Vries +1
Обзорная статья2019Цитирований: 2
ABI
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype
Darya Alizadeh, Robyn A. Wong, Xin Yang +11
Статья2019Цитирований: 2
ABI
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma
Margot J. Pont, Tyler Hill, Gabriel O. Cole +14
Статья2019Цитирований: 2
ABI
Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances
Meijun Zheng, Jianhan Huang, Aiping Tong +1
Обзорная статья2019Цитирований: 2
ABI
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
Bryan D. Choi, Xiaoling Yu, Ana P. Castaño +14
Статья2019Цитирований: 2
ABI
Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors
Rachel Grosser, Leonid Cherkassky, Navin K. Chintala +1
Обзорная статья2019Цитирований: 2
ABI